Industry Developments
Singapore
French firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease,...
2008-08-13South Korea
Boehringer Ingleheim is outpacing the South Korean over-the-counter (OTC) medicine sector. The German company's sales increased 1.9% in the first half of 2008, while most other competitors...
2008-08-13Japan
Merck & Co has launched its integrase inhibitor for HIV Isentress (raltegravir) in Japan through its local subsidiary Banyu.
2008-07-10United Kingdom
In an effort to penetrate emerging markets, UK specialty drugmaker Sinclair Pharma has contracted Mumbai-based Wockhardt to distribute four of its products in India. The deal runs...
2008-06-30China
Attracted by significant growth opportunities, US-based healthcare company Aetna has opened a representative office in Shanghai, which is the first step in offering insurance policies...
2008-06-30China
China is the premier investment focus for German firm Bayer, much like the US was in the 1990s. Indeed, Bayer believes it can supplant AstraZeneca as the number one drugmaker in the...
2008-06-23Brazil
India's Plethico Pharmaceuticals is targeting acquisitions in the US and Brazil in order to expand its Americas over-the-counter (OTC) and nutraceuticals businesses, according to...
2008-06-20Japan
Following the launch of its breakthrough rheumatoid arthritis therapeutic, US drugmaker Abbott Laboratories is looking to outperform the Japanese patented drug sector over the next...
2008-06-20
